White paper on best practices for translational research in neuroendocrine neoplasms

Other authors

Institut Català de la Salut

[Cros J] Department of Pathology, Beaujon Hospital (AP-HP), Université Paris Cité, Paris, France. [Casanovas O] ProCURE, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. [Castaño JP] Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain. Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Córdoba, Spain. Reina Sofia University Hospital, Córdoba, Spain. CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain. [Dayton T] Tissue Biology and Disease Modelling, European Molecular Biology Laboratory (EMBL) Barcelona, Barcelona, Spain. [Garcia Alvarez A] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Gastrointestinal and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gibert B] Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France

Vall d'Hebron Barcelona Hospital Campus

Publication date

2025-10-29T08:00:30Z

2025-10-29T08:00:30Z

2025-10



Abstract

Carcinoids; Genomics; Liquid biopsy


Carcinoides; Genómica; Biopsia líquida


Carcinoides; Genòmica; Biòpsia líquida


Basic and translational investigations play a crucial role in advancing our understanding of neuroendocrine neoplasms (NENs). In this white paper by the Basic and Translational Research Group of the European Neuroendocrine Tumor Society, we discuss the qualities and drawbacks of current disease models and propose good practices for integrating state-of-the-art technologies including bulk and single-cell genomics, transcriptomics, and proteomics in contemporary NEN research. We also provide insights on how to properly handle tissue samples (particularly when starting material is limited) and discuss technical hints of relevance when planning liquid biopsy or tumor immunology studies. Future translational studies of NENs will benefit from centralized biologic material biobanking, research design planning in the context of multi-expertise committees, as well as experimental protocol optimization and sharing across the NEN scientific community.

Document Type

Article


Published version

Language

English

Publisher

Wiley

Related items

Journal of Neuroendocrinology;37(10)

https://doi.org/10.1111/jne.70072

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)